gearwarehouseuk.com
No products in the cart.
Return To Shopgearwarehouseuk.com
No products in the cart.
Return To ShopBetaserc 8 exhibits several unique characteristics that contribute to its effectiveness. It operates mainly on H1 and H3 receptors in the vestibular system, thereby optimizing the treatment of dizziness and imbalance. Aside from its primary use, athletes and sports enthusiasts are increasingly recognizing its potential benefits in enhancing overall performance.
One of the primary advantages of Betaserc 8 lies in its ability to improve balance and coordination. This is crucial for athletes who require precision and stability during performance. Furthermore, athletes often experience dizziness or a feeling of imbalance from rigorous training. Betaserc 8 addresses these issues by facilitating better blood flow to the inner ear, which in turn strengthens sensory input and motor response.
Moreover, improved recovery is vital in high-intensity sports. Athletes using Betaserc 8 can benefit from faster recuperation after bouts of dizziness that might occur during training or competitive events. This leads to enhanced endurance levels, allowing athletes to maintain performance over longer periods. Additionally, there’s evidence suggesting that Betaserc 8 can alleviate fatigue, making it an attractive option for athletes seeking to push their limits without the drawbacks of physical dizziness.
Purchasing Betaserc 8 is seamless on our website. Users can navigate through an intuitive interface that allows for quick selections and fast checkouts. We prioritize user experience, ensuring all product descriptions are clear and concise. Our secure payment methods guarantee that personal information is protected throughout the transaction process. Additionally, all products listed are verified, ensuring customers receive only the highest quality medications.
Betaserc 8 may not be suitable for everyone. It is contraindicated in individuals with a known hypersensitivity to Betahistine or any of the product’s excipients. Caution is advised when considering use in patients with pheochromocytoma due to potential increases in blood pressure. Those with a history of gastrointestinal ulcers should also consult healthcare providers before starting Betaserc 8, as it may exacerbate existing conditions. Pregnant and breastfeeding women are advised to seek medical counsel before usage to understand the benefits and risks properly.
The recommended dosage for Betaserc 8 typically ranges from one to two tablets, taken three times daily. It is crucial to follow the guidelines provided by healthcare professionals, as individual needs may vary based on condition and activity level. Adjustments can be made depending on the athlete’s specific requirements or response to the medication. For optimal results, the tablets should be ingested with food to enhance absorption and minimize potential side effects. Monitoring for any adverse reactions is advised, especially when starting the medication.
| Active substance | Betahistine Dihydrochloride |
|---|---|
| Active Half-Life | 4 hours |
| Dosage | 24-48 mg/day |
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Not specific |
| Also known as | Betahistine hydrochloride |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Generally has minimal effect on blood pressure |
| Trade name | Serc, Betaserc |
| Storage conditions | Store at room temperature away from moisture and light |
| Chemical name | 2-(2-(methylamino)ethyl)pyridine |
| Formula | C8H12N2 |
| Substance class | Histamine analog |
| Main action | Histamine H1 receptor agonist and H3 receptor antagonist |
| Half-life | 3-4 hours |
| Dosage (medical) | Typically 8-48 mg per day in divided doses |
| Dosage (sports) | Not applicable |
| Effects | Improves microcirculation and vascular permeability, enhances inner ear blood flow |
| Side effects | Headache, nausea, dyspepsia, sometimes dizziness |
| Use in sports | None |
| Manufacturer | Abbott |
Reviews
There are no reviews yet.